![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:732993 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of GABARAPL2 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:732993 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GABARAPL2 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | increases expression | ISO | RGD:732993 | 6480464 | Ethinyl Estradiol results in increased expression of GABARAPL2 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:732993 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GABARAPL2 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:620510 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GABARAPL2 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:620510 | 6480464 | Tetrachlorodibenzodioxin affects the expression of GABARAPL2 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:620510 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GABARAPL2 mRNA | CTD | PMID:19490992 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:732993 | 6480464 | Tetrachlorodibenzodioxin affects the expression of GABARAPL2 mRNA | CTD | PMID:21570461 | 2,6-dinitrotoluene | affects expression | ISO | RGD:620510 | 6480464 | 2, 6-dinitrotoluene affects the expression of GABARAPL2 mRNA | CTD | PMID:21346803 | 3H-1,2-dithiole-3-thione | decreases expression | ISO | RGD:620510 | 6480464 | 1, 2-dithiol-3-thione results in decreased expression of GABARAPL2 mRNA | CTD | PMID:19162173 | 4-nitrophenol | decreases expression | ISO | RGD:732993 | 6480464 | 4-nitrophenol results in decreased expression of GABARAPL2 mRNA | CTD | PMID:34673133 | 6-propyl-2-thiouracil | decreases expression | ISO | RGD:620510 | 6480464 | Propylthiouracil results in decreased expression of GABARAPL2 mRNA | CTD | PMID:30047161 | acetamide | decreases expression | ISO | RGD:620510 | 6480464 | acetamide results in decreased expression of GABARAPL2 mRNA | CTD | PMID:31881176 | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of GABARAPL2 mRNA | CTD | PMID:27153756 | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of GABARAPL2 gene | CTD | PMID:27153756 | all-trans-retinoic acid | increases expression | ISO | RGD:732993 | 6480464 | Tretinoin results in increased expression of GABARAPL2 mRNA | CTD | PMID:16788091 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of GABARAPL2 mRNA | CTD | PMID:23724009 | amitrole | decreases expression | ISO | RGD:620510 | 6480464 | Amitrole results in decreased expression of GABARAPL2 mRNA | CTD | PMID:30047161 | ammonium chloride | affects expression | ISO | RGD:620510 | 6480464 | Ammonium Chloride affects the expression of GABARAPL2 mRNA | CTD | PMID:16483693 | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of GABARAPL2 mRNA | CTD | PMID:33212167 | arsenite(3-) | decreases expression | ISO | RGD:732993 | 6480464 | arsenite results in decreased expression of GABARAPL2 mRNA | CTD | PMID:33053406 | arsenous acid | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of GABARAPL2 mRNA | CTD | PMID:20458559 | benzo[a]pyrene | increases expression | ISO | RGD:732993 | 6480464 | Benzo(a)pyrene results in increased expression of GABARAPL2 mRNA | CTD | PMID:22228805 | bisphenol A | affects expression | ISO | RGD:620510 | 6480464 | bisphenol A affects the expression of GABARAPL2 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | RGD:732993 | 6480464 | bisphenol A results in increased expression of GABARAPL2 mRNA | CTD | PMID:33221593 | bisphenol A | increases expression | ISO | RGD:620510 | 6480464 | bisphenol A results in increased expression of GABARAPL2 mRNA | CTD | PMID:33296240 | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to GABARAPL2 gene] | CTD | PMID:28238834 | chloroquine | increases expression | EXP | | 6480464 | Chloroquine results in increased expression of GABARAPL2 protein | CTD | PMID:36482696 | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of GABARAPL2 mRNA | CTD | PMID:27392435 | clobetasol | increases expression | ISO | RGD:732993 | 6480464 | Clobetasol results in increased expression of GABARAPL2 mRNA | CTD | PMID:27462272 | clofibric acid | affects expression | ISO | RGD:620510 | 6480464 | Clofibric Acid affects the expression of GABARAPL2 mRNA | CTD | PMID:17602206 | clozapine | increases expression | EXP | | 6480464 | Clozapine results in increased expression of GABARAPL2 protein | CTD | PMID:36482696 | crocidolite asbestos | decreases expression | ISO | RGD:732993 | 6480464 | Asbestos, Crocidolite results in decreased expression of GABARAPL2 mRNA | CTD | PMID:29279043 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of GABARAPL2 mRNA | CTD | PMID:20106945 | diarsenic trioxide | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of GABARAPL2 mRNA | CTD | PMID:20458559 | dibutyl phthalate | increases expression | ISO | RGD:732993 | 6480464 | Dibutyl Phthalate results in increased expression of GABARAPL2 mRNA | CTD | PMID:21266533 | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of GABARAPL2 mRNA | CTD | PMID:28302478 | dioxygen | increases expression | ISO | RGD:732993 | 6480464 | Oxygen deficiency results in increased expression of GABARAPL2 mRNA | CTD | PMID:22629407 | dioxygen | multiple interactions | ISO | RGD:732993 | 6480464 | Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of GABARAPL2 mRNA] | CTD | PMID:22629407 | ethanol | increases expression | ISO | RGD:732993 | 6480464 | Ethanol results in increased expression of GABARAPL2 mRNA | CTD | PMID:30319688 | ethanol | affects expression | ISO | RGD:732993 | 6480464 | Ethanol affects the expression of GABARAPL2 mRNA | CTD | PMID:30319688 | ethyl methanesulfonate | increases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in increased expression of GABARAPL2 mRNA | CTD | PMID:23649840 | finasteride | increases expression | ISO | RGD:620510 | 6480464 | Finasteride results in increased expression of GABARAPL2 mRNA | CTD | PMID:24136188 | gamma-hexachlorocyclohexane | decreases expression | ISO | RGD:620510 | 6480464 | Hexachlorocyclohexane results in decreased expression of GABARAPL2 mRNA | CTD | PMID:17785943 | gentamycin | increases expression | ISO | RGD:620510 | 6480464 | Gentamicins results in increased expression of GABARAPL2 mRNA | CTD | PMID:33387578 | glafenine | decreases expression | ISO | RGD:620510 | 6480464 | Glafenine results in decreased expression of GABARAPL2 mRNA | CTD | PMID:24136188 | Heptachlor epoxide | increases expression | ISO | RGD:732993 | 6480464 | Heptachlor Epoxide results in increased expression of GABARAPL2 mRNA | CTD | PMID:25270620 | ketoconazole | increases expression | ISO | RGD:620510 | 6480464 | Ketoconazole results in increased expression of GABARAPL2 mRNA | CTD | PMID:37077353 | leflunomide | increases expression | ISO | RGD:620510 | 6480464 | leflunomide results in increased expression of GABARAPL2 mRNA | CTD | PMID:24136188 | methamphetamine | increases methylation | ISO | RGD:732993 | 6480464 | Methamphetamine results in increased methylation of GABARAPL2 promoter | CTD | PMID:26307267 | methapyrilene | increases expression | ISO | RGD:620510 | 6480464 | Methapyrilene results in increased expression of GABARAPL2 mRNA | CTD | PMID:30467583 | methimazole | decreases expression | ISO | RGD:620510 | 6480464 | Methimazole results in decreased expression of GABARAPL2 mRNA | CTD | PMID:30047161 | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of GABARAPL2 mRNA | CTD | PMID:23649840 | nickel atom | multiple interactions | ISO | RGD:732993 | 6480464 | MT1 affects the reaction [Nickel affects the expression of GABARAPL2 mRNA], MT2 affects the reaction [Nickel affects the expression of GABARAPL2 mRNA] | CTD | PMID:16166738 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of GABARAPL2 mRNA | CTD | PMID:22230336 | perfluorononanoic acid | increases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in increased expression of GABARAPL2 mRNA | CTD | PMID:25812627 | perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of GABARAPL2 mRNA | CTD | PMID:25812627 | sodium arsenite | multiple interactions | ISO | RGD:732993 | 6480464 | [sodium arsenite co-treated with Dietary Fats] results in increased expression of GABARAPL2 mRNA | CTD | PMID:30097599 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of GABARAPL2 protein | CTD | PMID:30528433 | Soman | decreases expression | ISO | RGD:620510 | 6480464 | Soman results in decreased expression of GABARAPL2 mRNA | CTD | PMID:19281266 | sulfadimethoxine | decreases expression | ISO | RGD:620510 | 6480464 | Sulfadimethoxine results in decreased expression of GABARAPL2 mRNA | CTD | PMID:30047161 | thioacetamide | decreases expression | ISO | RGD:620510 | 6480464 | Thioacetamide results in decreased expression of GABARAPL2 mRNA | CTD | PMID:34492290 | trichostatin A | affects expression | EXP | | 6480464 | trichostatin A affects the expression of GABARAPL2 mRNA | CTD | PMID:28542535 | trovafloxacin | increases expression | EXP | | 6480464 | trovafloxacin results in increased expression of GABARAPL2 mRNA | CTD | PMID:33609687 | trovafloxacin | multiple interactions | EXP | | 6480464 | TNF protein inhibits the reaction [trovafloxacin results in increased expression of GABARAPL2 mRNA] | CTD | PMID:33609687 | valproic acid | increases expression | ISO | RGD:732993 | 6480464 | Valproic Acid results in increased expression of GABARAPL2 mRNA | CTD | PMID:19136453 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of GABARAPL2 mRNA | CTD | PMID:29154799 | zinc atom | affects expression | EXP | | 6480464 | Zinc affects the expression of GABARAPL2 mRNA | CTD | PMID:16979875 | zinc(0) | affects expression | EXP | | 6480464 | Zinc affects the expression of GABARAPL2 mRNA | CTD | PMID:16979875 | |